Company intelligence / Profile preview

Baker Bros. Advisors

New York, New York, United States

Ownership: Private
Development stage: Other

Overview

Baker Bros. Advisors is a leading hedge fund specializing exclusively in biotechnology and healthcare investments. The fund is known for deep scientific due diligence and concentrated, long-term positions in late-stage and catalyst-driven biopharma companies. They do not conduct clinical trials or develop therapies directly, but are influential large shareholders and board members within their biotech investment portfolio, with a track record of high financial returns in the sector.

Industry: Investors

Partnerships

Frequent large investments and board representation in portfolio biotech companies (e.g., Seagen, BeiGene, Incyte, Acadia Pharmaceuticals, Summit Therapeutics)Past collaboration with Yale University endowment (as an investor)

Beyond the preview

Go deeper on Baker Bros. Advisors.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Baker Bros. Advisors.

Explore the full profile